BioLargo, Inc. (BLGO)
OTCMKTS · Delayed Price · Currency is USD
0.1620
-0.0080 (-4.71%)
Mar 31, 2026, 3:35 PM EST

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
ONM Environmental
5.91M15.60M11.44M4.37M1.42M
ONM Environmental Growth
-62.14%36.34%161.55%208.25%-9.50%
BLEST
2.55M3.20M2.40M1.94M1.64M
BLEST Growth
-20.39%33.38%23.37%18.84%55.71%
BioLargo Canada
86.00K72.00K30.00K1,000.0012.00K
BioLargo Canada Growth
19.44%140.00%2900.00%-91.67%-67.57%
Intersegment Revenue
-771.00K-1.09M-1.66M-495.00K-681.00K
BioLargo Corporate
---5.00K7.00K
BioLargo Corporate Growth
----28.57%-50.00%
Clyra Medical
--20.00K56.00K139.00K
Clyra Medical Growth
---64.29%-59.71%-42.08%
Total
7.77M17.78M12.23M5.88M2.53M
Total Growth
-56.32%45.37%107.85%132.48%4.07%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
United States
7.77M17.78M12.23M5.88M2.53M
United States Growth
-56.32%45.37%107.85%132.48%4.07%
Total
7.77M17.78M12.23M5.88M2.53M
Total Growth
-56.32%45.37%107.85%132.48%4.07%
Source: S&P Global Market Intelligence.